The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of Board Meeting held on December 06 2016

7 Dec 2016 07:50

RNS Number : 1724R
Subex Limited
07 December 2016
 

 

 

 

 

 

 

 

 

December 07, 2016

 

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

Dear Sirs,

Sub: Outcome of the Board Meeting held on December 06, 2016

Please be informed that the agenda item stated hereunder was discussed and approved at the Board Meeting held on December 06, 2016 at Mumbai:

 

· Unaudited standalone and consolidated Financial Results of the Company for the quarter and half year ended September 30, 2016.

 

Please find enclosed:

Ø The consolidated Financial Results of the Company for the quarter and half year ended September 30, 2016.

 

We request you to take the aforesaid notification on record.

 

 

Yours faithfully

For and on behalf of Subex Limited

 

 

 

Ganesh K V

Chief Financial Officer, Global Head -Legal and Company Secretary

Statement of Consolidated Unaudited Results for the quarter and six months ended September 30, 2016

(Rs. In lakhs)

Consolidated

Particulars

3 months ended September 30,

Preceding 3 months ended June 30,

Corresponding 3 months ended September 30,

Year to date figures for the six months ended September 30,

2016

2016

2015

2016

2015

Unaudited

Unaudited

Notes 3 & 4

Unaudited

Notes 3 & 4

1

Income from operations

Net sales/ income from operations

8,336

8,334

7,928

16,670

15,265

Total income from operations (net)

8,336

8,334

7,928

16,670

15,265

2

Expenses

(a)

Cost of hardware, software and support charges (refer note 10)

44

252

77

296

96

(b)

Employee benefits expense (refer note 11)

4,175

4,067

3,895

8,242

8,034

(c)

Other expenditure

2,689

2,466

2,293

5,155

4,460

(d)

Depreciation and amortisation expense

117

112

105

229

207

(e)

Exchange fluctuation (gain)/loss (net)

(211)

(818)

372

(1,029)

1,895

Total expenses

6,814

6,079

6,742

12,893

14,692

3

Profit from operations before other income and finance costs (1-2)

1,522

2,255

1,186

3,777

573

4

Other income (refer note 7)

268

229

31

497

84

5

Profit from ordinary activities before finance costs (3+4)

1,790

2,484

1,217

4,274

657

6

Finance costs

(a)

Interest on FCCBs

128

134

1,066

262

2,363

(b)

Interest on term loan

167

201

244

368

475

(c)

Other finance costs

223

223

332

446

652

Total finance costs

518

558

1,642

1,076

3,490

7

Profit/(loss) from ordinary activities before tax (5-6)

1,272

1,926

(425)

3,198

(2,833)

8

Tax expense (net)

298

108

637

406

837

9

Net profit/ (loss) for the period (7-8)

974

1,818

(1,062)

2,792

(3,670)

10

Other comprehensive income, net of taxes

(244)

(846)

(869)

(1,090)

(332)

11

Total comprehensive income (9+10)

730

972

(1,931)

1,702

(4,002)

12

Paid up share capital [face value of Rs. 10 (March 31, 2016: Rs. 10)]

50,691

50,475

26,402

50,691

26,402

13

Earnings/(loss) per share (of Rs. 10/- each) (not annualised in case of the interim periods):

(a)

- Basic

0.19

0.36

(0.50)

0.55

(1.79)

(b)

- Diluted

0.19

0.36

(0.50)

0.55

(1.79)

 

Subex Limited

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

Statement of consolidated assets and liabilities

( Rs. in Lakhs)

Particulars

As at September 30, 2016

(Unaudited)

ASSETS

Non-current assets

Property, plant and equipment

565

Goodwill

76,772

Other intangible assets

64

Financial assets:

Loans and advances

616

Others

177

Other non-current assets

2,499

80,693

Current assets

Financial assets:

Loans and advances

522

Trade receivables

10,266

Cash and cash equivalents

9,481

Other financial assets

3,759

Other current assets

1,803

25,831

Total assets (A+B)

106,524

EQUITY AND LIABILITIES

Equity

Equity share capital

50,691

Other equity

25,120

Total equity

75,811

Non-current liabilities

Provisions

312

312

Current liabilities

Financial liabilities:

Borrowings

9,900

Trade payables

1,750

Other current financial liabilities

14,571

Provisions

1,583

Other current liabilities

2,597

30,401

Total liabilities (D+E)

30,713

Total equity and liabilities (C+D+E)

106,524

 

Notes:

1 The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on December 06, 2016.

2 The financial results of Subex Limited (Standalone Information):

( Rs. in Lakhs)

Particulars

3 months ended September 30,

Preceding 3 months ended June 30,

Corresponding 3 months ended September 30,

Year to date figures for the six months ended September 30,

2016

2016

2015

2016

2015

Unaudited

Unaudited

Notes 3 & 4

Unaudited

Notes 3 & 4

Net sales/ income from operations

7,505

7,673

7,267

15,178

13,683

Profit/(loss) from ordinary activities before tax

401

646

(1,534)

1,047

(3,245)

Profit/(loss) from ordinary activities after tax

321

637

(1,832)

958

(3,593)

 

3 The financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ("Ind AS") 34 on Interim Financial Reporting prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016.

The Company has opted to avail relaxation provided by SEBI vide the aforesaid circular dated July 5, 2016 in respect of disclosure requirements for corresponding figures of earlier periods. Accordingly, the financial results for the year ended March 31, 2016 and balance sheet as at March 31, 2016 have not been presented. The reserves (excluding revaluation reserve), as per the balance sheet of the previous accounting year not being mandatory, have not been presented.

The Results for the quarter and six months ended September 30, 2015 has not been subjected to limited review or audit. However, the management has exercised necessary diligence to ensure that the financial results for the quarter and six months ended September 30, 2015 provide a true and fair view of the Company's affairs.

4

Consequent to transition from the Previous GAAP to Ind AS, the reconciliation of profit/loss after tax is September 30, 2015 and year to date figures ('YTD') for the six months ended September 30, 2015:

provided below for the corresponding 3 months ended

( Rs. in Lakhs)

Particulars

Corresponding

3 months ended September 30, 2015

YTD six

months ended September 30, 2015

Net profit under previous GAAP

1,560

1,085

Add/(less): Ind-AS adjustments income/(loss):

(i) Measurement of Foreign Currency Convertible Bonds ('FCCBs') at fair value

(a) Impact on finance cost due to effective interest rate and transfer of interest no longer payable to retained earnings on conversion of FCCBs into equity shares

(b) Impact on foreign exchange due to change in carrying value of FCCBs and related account balances and transfer of exchange gain to retained earnings on conversion of FCCBs into equity shares

(1,989)

(599)

(3,761)

(946)

(ii) Deferral of revenue pertaining to free support services

(iii) Others (net)

(26)

(8)

(40)

(8)

Net loss after tax as per Ind-AS

(1,062)

(3,670)

5

(a) The Board in its meeting held on May 14, 2015, approved the reset of conversion price of the FCCBs III, which are convertible into equity shares of the Company, from Rs. 22.79 to Rs. 13.00 per equity share. Subsequently, the reset of the conversion price have been approved bythe shareholders in the annual general meeting held on June 19, 2015 and the bondholders in their meeting held on August 5, 2015. The Board in its meeting held on August 26, 2015, approved August 26, 2015 as the effective date of reset of conversion price of Rs. 13.00 per share.

(b) As at March 31, 2015, the Company had outstanding FCCBs III with face value of US$ 81.53 Million, out of which FCCBs III with face value of US$ 77.93 Million have been converted till the quarter and six months ended September 30, 2016 as detailed below:

Financial year/ period

FCCBs converted

US$ Million

Conversion rate per US$

Conversion price

No. of equity shares

2015-16

76.98

Rs.56.0545

Rs.22.79/  Rs.13.00

319,889,071

2016-17

Quarter ended June 30, 2016

0.45

Rs. 56.0545

Rs. 13.00

1,940,348

Quarter ended September 30, 2016

0.50

Rs. 56.0545

Rs. 13.00

2,155,942

(c) The face value and fair value of FCCBs outstanding as at September 30, 2016 are as follows:

Face value

Fair value

Particulars

US$ Million

Rs. in Lakhs

US$ Million

Rs. in Lakhs

FCCBs I

FCCBs II

FCCBs III

1.00

1.40

3.60

666

933

2,398

1.31

1.94

3.46

873

1,290

2,302

Total

6.00

3,997

6.71

4,465

As a result of reset in conversion price of FCCBs III, the said bonds with outstanding face value of US$ 3.60 Million as at September 30, 2016 would potentially be converted into 15,522,785 equity shares at an exchange rate of Rs. 56.0545/US$ with a conversion price of Rs. 13.00 per equity share.

(d) The FCCB holders in their respective meetings have approved the deferral of aggregate interest of US$ 0.73 Million (fair value of US$ 0.71 Million), i.e. Rs. 486 Lakhs (fair value of Rs. 475 Lakhs) in respect of outstanding FCCBs III with face value of US$ 3.60 Million for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017.

6

During the year ended March 31, 2016, pursuant to the Interest Waiver Letter dated March 26, 2016, the lenders of term loan of US$ 12 Million to Subex Americas Inc. had waived the interest liability upto the date of such letter and interest accruing thereafter upto August 22, 2016. Further, interest rate has been revised from 10.5% per annum to 5% per annum, effective August 22, 2016. Subsequently, the interest waiver has been further extended till March 31, 2017, the effective date for the applicability of revised interest rate of 5% per annum has been extended to April 01, 2017 and the repayment date for US$ 6.5 Million loan out of US$ 12 Million has been extended from August 22, 2016 to March 31, 2017, and remaining balance of US$ 3.5 Million and US$ 2 Million is due for repayment on March 31, 2017 and June 30, 2017 respectively.

7

The Company had remitted the withholding taxes in respect of FCCBs III in accordance with the provisions of the Income Tax Act, 1961 amounting to Rs. 1,025 Lakhs upto September 30, 2016. Pursuant to the conversion of FCCBs III into equity shares of the Company, the interest accrued but not due is considered no longer payable. The management basis expert advice, is of the view that the withholding taxes paid by the Company in respect of the aforesaid interest, are recoverable from income tax department and/or are adjustable against its other withholding taxes obligations. Accordingly, the Company has revised the returns of withholding taxes and adjusted withholding taxes ofRs. 455 Lakhs during the six months ended September 30, 2016 (quarter ended June 30, 2016 : Rs. 205 Lakhs) on salary, professional services and others, by write back of withholding taxes on interest on FCCBs paid earlier, and such write back is included under other income.

8

During the year ended March 31, 2016, the Company assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex Americas Inc., amounting to Rs. 18,606 Lakhs. Based on future operational plan, projected cash flows and valuation carried out by an external valuer, the Company made an impairment provision ofRs. 8,870 Lakhs during the year ended March 31, 2016 towards the carrying value of goodwill relating to its investment in the said subsidiary. There is no change in the management's assessment as regards aforementioned carrying value of goodwill as at September 30, 2016 and in view of the management, no further provision for diminution is considered necessary as at September 30, 2016.

9

During the year ended March 31, 2016, the Company assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex (UK) Limited, amounting to Rs. 67,036 Lakhs. Based on the future operational plan, projected cash flows and the valuation carried out by an external valuer, the management was of the view that, the aforesaid carrying value of goodwill as at March 31, 2016 relating to its investment in the said subsidiary was appropriate. There is no change in the management's assessment as regards aforementioned carrying value of goodwill as at September 30, 2016.

 

Cost of hardware, software and support charges for the quarters ended September 30, 2016, June 30, 2016 and September 30, 2015 is net of reversal of provision no longer required, amounting to Rs. Nil, Rs. Nil and Rs. Nil, respectively and that for the six months ended September 30, 2016 and September 30, 2015 amounting to Rs. Nil and Rs. 173 Lakhs, respectively.

Employee benefits expenses and sub-contract charges for the quarters ended September 30, 2016, June 30, 2016 and September 30, 2015 is net of reversal of provision no longer required, in respect of employee incentives, amounting to Rs. Nil, Rs. Nil and Rs. 384 Lakhs, respectively and that for the six months ended September 30, 2016 and September 30, 2015 amounting to Rs. Nil and Rs. 453 Lakhs, respectively.

Pursuant to the approval of the Board of Directors, the Group has discontinued the operations of two of its subsidiaries with effect from April 01, 2013. The details of unaudited results of the discontinued businesses consolidated in the above results are as follows:

( Rs. in Lakhs)

Particulars

3 months ended September 30,

Preceding 3 months ended June 30,

Corresponding 3 months ended September 30,

Year to date figures for the six months ended September 30,

2016

2016

2015

2016

2015

Unaudited

Unaudited

Notes 3 & 4

Unaudited

Notes 3 & 4

Total income

-

-

-

-

-

(Loss)/ Profit before tax

(2)

(1)

(1)

(3)

(2)

Profit/ (Loss) after tax

(1)

54

2

53

1

 

The Company is engaged in the business of software products and related services. These, in the context of Ind-AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Company has not made any additional segment disclosures.

Previous period figures have been regrouped/ reclassified, wherever necessary to confirm to current period's classification.

Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

Surjeet Singh

Managing Director & CEO

For further details on the results, please visit our website: www.subex.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMAKODQOBDKFBK
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.